For Pharmaceutical Companies :
As a commercial partner, to offer clinical test after product launched.
As a CRO, to organize Clinical Trials, recruiting special gene-type patients (Among the current 25 hospitals which 3G Biotech built CDx joint lab, 20 of them are national level site of clinical trials.)

As the leader of Companion Diagnostics in China, 3G Biotech has built 25 joint MDx labs within Chinese big hospitals. For the joint labs, 3G Biotech offers same equipments, same reagents, same SOP, same trained technician.
We are building “Highway” for clinical practice to offer kinds of drug-related gene tests.
So far, three pharmaceutical companies have been strategic partners. 3G Biotech offers services to their launched products, especially in cancer therapy.

For IVD Companies :
To license-In intellectual property of diagnostic reagents.
To open the joint-lab network as a "highway", welcoming kinds of new approaches for companion diagnostics to be a part of the joint-labs.
To be distributor and/or toll manufacturer for companion diagnostic reagents.

For New Medicine Research Companies :
To be partner for finding Chinese partners for co-development in Chinese market, 3G Biotech would take care of the biomarker, the other Chinese pharmaceutical company responsible for NDA (new drug application).
To license-In biomarker intellectual property.

For Academy and Research Institute :
To be partner for international clinical trial, organizing Chinese hospitals involve in.
To license-In biomarker intelectural property for developing diagnostic reagents.